Endometrial Cancer Clinical Trials in Prague
7 recruitingPrague, Czechia
Showing 1–7 of 7 trials
Recruiting
Phase 3
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Endometrial Cancer
Merck Sharp & Dohme LLC1,123 enrolled232 locationsNCT06952504
Recruiting
Phase 3
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Endometrial CancerMalignant Solid Tumour
AstraZeneca700 enrolled294 locationsNCT07044336
Recruiting
Phase 3
Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma
Endometrial Cancer
Karyopharm Therapeutics Inc276 enrolled217 locationsNCT05611931
Recruiting
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
Endometrial CancerEndometrioid AdenocarcinomaEndometrial Cancer Stage I
Memorial Sloan Kettering Cancer Center1,715 enrolled19 locationsNCT04291612
Recruiting
Molecular Classification in Relation to Prevention of Endometrial Cancer Recurrence and Lifestyle Factors
Endometrial CancerGenetic PredispositionRisk Behavior
Lukas Vanek280 enrolled1 locationNCT06680791
Recruiting
Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses.
Ovarian CancerCervical CancerEndometrial Cancer+6 more
Universitaire Ziekenhuizen KU Leuven200 enrolled4 locationsNCT05610501
Recruiting
Phase 3
Prehabilitation in Gynaecological Cancer Patients
Ovarian CancerEndometrial CancerOvarian Cancer Stage III+2 more
Charles University, Czech Republic64 enrolled1 locationNCT04789694